Join our clinical trial

Paradigm Biopharmaceuticals Ltd is not currently recruiting for clinical trials. Results for the two trials listed below that have recently closed have been published via ASX announcements.

Paradigm is in planning for its next phase of clinical trials. All information regarding future recruitment activity will be published via our ASX announcements, on our website, and via an appropriate clinical trial registry.

COMPLETED: Phase 2 clinical trial for patients with BMLs and Osteoarthritis

A phase 2b, randomised double blind placebo controlled multicentre study to evaluate the effects of pentosan polysulfate sodium on treating pain in subjects with osteoarthritis of the knee and subchondral bone marrow lesions.

Details can be found on the ANZCTR website.

COMPLETED: Phase 2A clinical trial for patients with Ross River Virus

A pilot study to investigate the effects of pentosan polysulfate sodium in Ross River.

Details can be found on the ANZCTR website.